Legislative Activity

The "Meat and Poultry Special Investigator Act of 2025" establishes an Office of the Special Investigator for Competition Matters within the Department of Agriculture. This office will investigate and prosecute violations of the Packers and Stockyards Act related to competition and trade practices in the food and agriculture sector, serve as a liaison to other agencies, and coordinate with the Department of Homeland Security on national security issues in the food and agriculture sector. The Special Investigator has the authority to bring civil or administrative actions against entities regulated under the Packers and Stockyards Act.

The "No Tax Breaks for Union Busting (NTBUB) Act" amends the Internal Revenue Code to deny tax deductions for employer expenses used to influence employees regarding union activities, including union elections and collective bargaining. It requires detailed reporting of such expenditures on tax returns, with significant penalties for non-compliance, while providing exemptions for certain communications and activities. The Act aims to prevent taxpayer subsidization of employer interference in workers' rights to organize and collectively bargain.

The "Preserve Access to Affordable Generics and Biosimilars Act" aims to foster competition in the pharmaceutical market by preventing brand-name drug and biosimilar manufacturers from entering into anticompetitive agreements that delay or prevent the entry of generic drugs and biosimilars. It prohibits agreements where generic or biosimilar applicants receive compensation to limit competition, with certain exceptions, and empowers the Federal Trade Commission (FTC) to enforce these prohibitions. The Act also requires companies to certify that their agreements with generic drug or biosimilar manufacturers are complete and include all related terms and clarifies that forfeiture of the 180-day exclusivity period can occur if an agreement violates the Federal Trade Commission Act. Finally, the Act directs the FTC to submit a recommendation on a potential amendment regarding the exclusion of certain damage claims and sets a statute of limitations for enforcement proceedings.

The "Trade Review Act of 2025" mandates that the President must notify Congress within 48 hours of imposing or increasing import duties, explaining the justification and potential economic effects. Any such duty will expire after 60 days unless Congress approves it through a joint resolution. Congress can also disapprove and nullify a duty through a joint resolution. This act excludes antidumping and countervailing duties and establishes expedited procedures for congressional review.

The Fair Day in Court for Kids Act of 2025 aims to ensure that unaccompanied children have legal representation in immigration proceedings by providing government-funded counsel. It mandates that these children receive complete copies of their immigration files and have sufficient time to review them, and it also requires the Department of Homeland Security to allow counsel access to detained non-citizens. The Act directs the Office of Refugee Resettlement to develop guidelines for legal representation and requires annual reports on the provision of counsel to unaccompanied children. Additionally, it allows unaccompanied children to reopen their immigration cases if they were not provided with appointed counsel, and it authorizes the necessary appropriations for implementation.

The Federal Firearm Licensee Act aims to modernize and strengthen regulations for firearm dealers by enhancing security measures, mandating electronic record-keeping, increasing inspection frequency, and clarifying licensing requirements. It also repeals certain restrictions on the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) and increases penalties for violations of firearm laws. This act seeks to hold firearm dealers accountable, reduce illegal firearm diversion, and improve law enforcement efforts against firearm trafficking and violence. The bill also addresses background checks for employees and requires additional reporting and analysis of dealer inspections.

The "Affordable Prescriptions for Patients Act" amends patent infringement laws to include patents related to the manufacturing of biological products. It sets limits on the number of patents a reference product sponsor can assert in an infringement action against a biological product applicant, with exceptions for certain circumstances and types of patents. These changes aim to balance patent protection with the goal of increasing access to affordable biological medications. The amendments apply to applications submitted after the enactment of this act.

The Stop STALLING Act aims to prevent pharmaceutical companies from filing frivolous petitions with the intent of delaying the approval of generic drugs and hindering competition. It empowers the Federal Trade Commission (FTC) to take civil action against those who submit "sham" petitions, defined as objectively baseless petitions intended to interfere with a competitor's business. Penalties for submitting sham petitions include substantial fines, potentially based on the revenue earned due to the delayed drug approval. The Act clarifies that it does not alter existing antitrust laws and applies to petitions submitted after the Act's enactment.

The "Drug Competition Enhancement Act" aims to prevent pharmaceutical manufacturers from engaging in "product hopping," a practice that stifles generic and biosimilar competition by switching patients to a new version of a drug before lower-cost alternatives can enter the market. It defines specific actions as unfair competition, including hard switches (removing the original drug) and soft switches (disadvantaging the original drug), while providing manufacturers the opportunity to justify their actions under certain circumstances. The bill empowers the Federal Trade Commission (FTC) to enforce these provisions through investigations, injunctions, and financial penalties, ensuring a fair marketplace for drug competition. This act does not limit other antitrust laws or FTC authority.

The "Prescription Pricing for the People Act of 2025" directs the Federal Trade Commission (FTC) to investigate and report to Congress on the practices of pharmacy benefit managers and other intermediaries in the pharmaceutical supply chain, including their impact on drug prices and competition. The FTC is required to identify any legal or regulatory barriers hindering antitrust enforcement in the pharmaceutical industry and suggest improvements for transparency and competition. Additionally, the FTC must report on complaints of anticompetitive behavior by sole-source drug manufacturers and recommend policies to enhance enforcement.

The IDEA Full Funding Act amends the Individuals with Disabilities Education Act to authorize and appropriate specific funding amounts for fiscal years 2026 through 2035 and subsequent years. It aims to increase federal funding for special education, gradually working towards full federal funding by fiscal year 2035. The funding is calculated based on the number of children with disabilities receiving special education and the average per-pupil expenditure in public schools. This act ensures that funds are available to states to support special education and related services for children with disabilities.

The "Tax Fairness for Workers Act" allows above-the-line tax deductions for union dues and other employee-related business expenses. This amends the Internal Revenue Code to ensure these deductions are not subject to certain limitations, providing tax relief for workers. These changes will be effective for taxable years beginning after December 31, 2024.

The Impact Aid Infrastructure Partnership Act aims to improve school facilities in federally impacted communities through a Federal-local partnership. It authorizes funds for both competitive and formula grants to local educational agencies eligible for Impact Aid, prioritizing those with the most critical facility needs and limited financial resources. These grants can be used for construction, renovation, or repair of school facilities, with a focus on addressing health, safety, and accessibility issues. The Act also requires local education agencies to contribute a percentage of the project cost, based on their learning opportunity threshold.

The CONNECT for Health Act of 2025 expands access to telehealth services under Medicare by removing geographic restrictions, expanding eligible practitioners and originating sites, and making waivers for Federally Qualified Health Centers and Native American health facilities permanent. It also enhances program integrity by clarifying fraud and abuse laws, authorizing additional funding for oversight, and addressing unusual billing patterns. Additionally, the act supports beneficiaries and providers by requiring the development of resources and training, reviewing quality measures, and mandating the publication of data on telehealth services. These changes aim to make telehealth a more accessible, high-quality, and permanent option for patients, particularly those in underserved areas.

The Stephen Hacala Poppy Seed Safety Act aims to protect public health by setting contamination limits for morphine and other illicit compounds in poppy seeds sold in interstate commerce. It directs the Department of Health and Human Services to establish these contamination levels, classifying poppy seeds exceeding these limits as adulterated and therefore illegal. The Act clarifies that contaminated poppy seeds remain subject to regulation under the Controlled Substances Act, ensuring continued oversight. This legislation seeks to prevent overdoses and protect consumers from unknowingly ingesting dangerous levels of opiates from contaminated poppy seeds.

The "Sanctioning Russia Act of 2025" mandates a wide range of sanctions on Russia, its government, affiliated individuals and entities, and sectors of its economy in response to actions against Ukraine. It requires the President to make regular determinations regarding Russia's behavior and imposes escalating penalties, including financial restrictions, import bans, and increased duties, if Russia refuses to negotiate peace, violates agreements, or takes further aggressive actions against Ukraine. The Act also targets international entities that support Russia's sanctioned activities and sets conditions for the termination and reimposition of sanctions based on Russia's adherence to peace agreements.

The "Workplace Violence Prevention for Health Care and Social Service Workers Act" directs the Secretary of Labor to establish an interim and final standard requiring healthcare and social service employers to develop and implement comprehensive workplace violence prevention plans. These plans must include risk assessments, hazard prevention measures, incident reporting procedures, and employee training. The Act also requires employers to maintain detailed records of violent incidents and submit annual summaries to the Secretary of Labor. Finally, facilities receiving Medicare funds must comply with the workplace violence prevention standard.

The "Paying a Fair Share Act of 2025" introduces a new tax on high-income taxpayers with an adjusted gross income exceeding $1,000,000, referred to as the "fair share tax". This tax aims to ensure wealthy individuals pay a minimum level of tax and contribute to deficit reduction. The tax is calculated based on a percentage of the taxpayer's adjusted gross income above a certain threshold, taking into account charitable contributions and other tax liabilities. The Act expresses the Senate's intention for broader tax system reforms, including eliminating loopholes and simplifying the tax code.

This resolution designates April 2025 as "Preserving and Protecting Local News Month" to highlight the importance of local news in American democracy. It recognizes the decline of local news outlets and the negative impact this has on informed citizens and communities. The resolution acknowledges local journalism as a public good and affirms its valuable contributions.

The "Convenient Contraception Act" amends the Public Health Service Act, mandating that group health plans and health insurance issuers provide enrollees with the option to obtain a 365-day supply of contraceptives. This Act ensures access without cost-sharing, aligning with existing preventive care mandates. The provisions will be effective for plan years starting on or after January 1, 2026, and requires the Secretaries of Health and Human Services, Labor, and the Treasury to conduct outreach to inform healthcare providers and individuals about the new requirements.